CHPA To Lobby Against FDA-Initiated Rx-To-OTC Switches
Congress should discourage FDA from pursuing Rx-to-OTC switches without the drug sponsor's approval, the Consumer Healthcare Products Association asserts
Congress should discourage FDA from pursuing Rx-to-OTC switches without the drug sponsor's approval, the Consumer Healthcare Products Association asserts